S&P 500

5.222,68

0,16%

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

ENZ

Enzo Biochem (ENZ)

Enzo Biochem Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:ENZ

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
13/03/2024	21h26	GlobeNewswire Inc.	Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update	NYSE:ENZ	Enzo Biochem Inc
28/02/2024	01h22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ENZ	Enzo Biochem Inc
27/02/2024	22h05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ENZ	Enzo Biochem Inc
27/02/2024	22h05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ENZ	Enzo Biochem Inc
14/02/2024	16h23	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:ENZ	Enzo Biochem Inc
13/02/2024	15h35	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NYSE:ENZ	Enzo Biochem Inc
03/02/2024	03h02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ENZ	Enzo Biochem Inc
03/02/2024	03h01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ENZ	Enzo Biochem Inc
03/02/2024	03h00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ENZ	Enzo Biochem Inc
01/02/2024	14h33	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ENZ	Enzo Biochem Inc
21/12/2023	22h48	Edgar (US Regulatory)	Form DEFR14A - Revised definitive proxy soliciting materials	NYSE:ENZ	Enzo Biochem Inc
21/12/2023	22h15	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NYSE:ENZ	Enzo Biochem Inc
15/12/2023	22h15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:ENZ	Enzo Biochem Inc
15/12/2023	22h01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ENZ	Enzo Biochem Inc
28/11/2023	23h16	Edgar (US Regulatory)	Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]	NYSE:ENZ	Enzo Biochem Inc
03/11/2023	22h07	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NYSE:ENZ	Enzo Biochem Inc
30/10/2023	22h01	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:ENZ	Enzo Biochem Inc
30/10/2023	21h50	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ENZ	Enzo Biochem Inc
11/09/2023	23h14	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NYSE:ENZ	Enzo Biochem Inc
06/09/2023	03h35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ENZ	Enzo Biochem Inc
28/07/2023	23h19	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NYSE:ENZ	Enzo Biochem Inc
24/07/2023	22h32	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ENZ	Enzo Biochem Inc
24/07/2023	22h20	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NYSE:ENZ	Enzo Biochem Inc
19/07/2023	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NYSE:ENZ	Enzo Biochem Inc
19/07/2023	03h42	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NYSE:ENZ	Enzo Biochem Inc
18/07/2023	19h19	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NYSE:ENZ	Enzo Biochem Inc
17/07/2023	19h38	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ENZ	Enzo Biochem Inc
10/07/2023	23h30	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NYSE:ENZ	Enzo Biochem Inc
10/07/2023	23h20	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ENZ	Enzo Biochem Inc
29/06/2023	23h14	Edgar (US Regulatory)	Form 11-K - Annual report of employee stock purchase, savings and similar plans	NYSE:ENZ	Enzo Biochem Inc